Cat:GMP-IVD-P044-Tg004
Awaiting product image
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-IVD-P044-Tg004 Categories ,

For more than 100mg, click here for inquiry. >>

Product Details

Genemedi produces core diagnostic ingredients for test of Infectious disease (peptic ulcer? and gastritis) and related syndrome. GeneMedi offers paired diagnostics grade Helicobacter pylori vacuolar cytotoxin A (Vac A) antibodies (monoclonal antibody, mab) and antigens for Infectious disease (peptic ulcer? and gastritis) rapid test kit of Helicobacter pylori vacuolar cytotoxin A (Vac A) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Infectious disease (peptic ulcer? and gastritis ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Helicobacter pylori?(H. pylori) is a Gram-negative bacterium that colonizes the human stomach. Approximately half of the human population worldwide is infected with?H. pylori.?One of the most extensively studied toxins produced by?H. pylori?is the Vacuolating cytotoxin A (VacA). Infection with?H. pylori?strains containing the toxigenic allelic?s1?form of VacA is associated with an increased risk of peptic ulceration and gastric cancer. VacA was named with reference to its ability to cause “vacuole”-like membrane vesicles in the cytoplasm of gastric cells.

Product Description

Cat No. of Pruducts

GMP-IVD-P044-Tg004-Ag01:Recombinant Helicobacter pylori (H. pylori) Vac A Protein

Product Name

Recombinant Helicobacter pylori (H. pylori) Vac A Protein

Target

Helicobacter pylori vacuolar cytotoxin A

Alias of Target/Biomarker

#N/A

Expression platform

E.coli

Isotypes

Recombinant Antigen

Bioactivity validation

Helicobacter pylori vacuolar cytotoxin A (Vac A) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Vac A level test of Infectious disease (peptic ulcer? and gastritis) and related syndrome evaluation

Tag

His

Products description

Recombinant Helicobacter pylori (H. pylori) Vac A Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.

Reconized/Reactive Species

Helicobacter pylori (H. pylori)

Purity

Purity: ≥95% (SDS-PAGE)

Application

Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Genemeidi Omicron Variant Products
test
Previous slide
Next slide

Cat No. of Pruducts

GMP-IVD-P044-Tg004-Ab01,GMP-IVD-P044-Tg004-Ab02:Anti-Helicobacter pylori (H. pylori) Vac A mouse monoclonal antibody (mAb)

Product Name

Anti-Helicobacter pylori (H. pylori) Vac A mouse monoclonal antibody (mAb)

Target

Alias of Target/Biomarker

#N/A

Expression platform

Hybridoma

Isotypes

Mouse IgG

Bioactivity validation

Helicobacter pylori (H. pylori) Helicobacter pylori vacuolar cytotoxin A (Vac A) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori vacuolar cytotoxin A (Vac A) antibodies in Vac A level test of Infectious disease (peptic ulcer? and gastritis) and related syndrome evaluation.

Tag

mFc

Products description

Anti-Helicobacter pylori (H. pylori) Vac A mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori vacuolar cytotoxin A (Vac A) antibodies.

Reconized/Reactive Species

Helicobacter pylori (H. pylori)

Purity

Purity: ≥95% (SDS-PAGE)

Application

ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1

Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.